View speaker details

Francis was appointed Vice President, Atlas Copco (China) Investment Co., Ltd. in August, 2016. Based in Shanghai, he oversees Atlas Copco’s operations in Greater China and Mongolia, with more than 35 legal entities.
Over the past 23 years, he has held various managerial positions with increased responsibility within Atlas Copco Group and has been working most of his time in different countries in Europe and Asia. Prior to his current position, he was the General Manager of Atlas Copco Singapore & Malaysia.
Francis is a Belgian citizen, and holds a Master’s degree in Business Administration.

View speaker details

With 23 years of China corporate development and investment banking experience, Eduardo is Managing Partner of ICP (InterChina Partners). ICP ranks among China’s top 5 mid-market Investment banks with more than 200 M&A and Divestment transactions successfully closed. The company employs 60 people and has offices in Beijing, Shanghai, Hong Kong and London. InterChina is member of Clearwater International, one of Europe’s leading investment banking firms. Eduardo is a member of several board of directors in China and APAC, a member of YPO and an associate professor in Cheung Kong Business School and IE for MBA executive education. Prior work experience with Credit Suisse Asset Management (Madrid) and Sinclair Roche & Temperley (London).

View speaker details

With 7-years experience across UK and China in strategic consulting and M&A, Adrian has been leading Grupo Antolin corporate development initiatives in China since 2018. Based in Shanghai, he has coordinated inorganic growth and business development activities to enhance Grupo Antolin’s leading position as major automotive interior component supplier. His expertise includes Joint Ventures negotiation and establishment, restructuring and divestment of jointly invested entities, closure and operational implementation of M&A deals and development of new strategic partnerships. He is familiar with the assessment, evaluation and integration process regarding equity deals and has experience in major legal, financial, tax, operational and strategic matters involved in the Joint Venture negotiation and set up procedures.

Before joining Grupo Antolin, he advised Spanish companies on Chinese market entry and growth strategies as Investment Officer at the Economic and Commercial Office of Spain in Shanghai, and provided in-depth insights on investment framework for foreign companies in China, industry analysis, investment trends reports and macroeconomic environment assessment.

Graduated in Law and Business Administration at the University of Valladolid (Spain), he holds a MSc in International Management & International Trade by the Spanish Trade&Investment Bureau (ICEX).

View speaker details

Michael has more than 20 years of experience in advising international companies on their operations in and with China. He has profound experience advising industrial clients in various sectors, covering all legal aspects of a typical investment deal like market entry and joint ventures, M&A restructuring and exit. Throughout his two decades’ practice, Michael has been gradually converging his energy on technology driven business and has built up his reputation and connections in the circle.

As the first Chinese partner of Taylor Wessing, Michael is now heading the firm's TMC practice for China. Besides his expertise regarding general corporate and commercial matters, he specializes in IT regulatory and data/privacy protection areas. Michael holds CIPP/E certification as granted by the International Association of Privacy Professionals (IAPP). At the same time, he frequently publishes articles and comments on IT and technology related legal topics.

Michael is National Vice Chair of the Legal & Competition Working Group under the European Chamber of Commerce. He also serves as an arbitrator of the Shanghai International Arbitration Center.

Michael studied law at the University of International Business and Economics in Beijing (UIBE), China, where he also completed his LLB and LLM degrees in 1997 and 2000 respectively. In 2006, Michael received his law doctorate from UIBE. In 1997, Michael was admitted to the Chinese bar. After practicing in domestic law firms, he worked in the Beijing office of a major international law firm from 2000 to 2002. In 2002, he joined Taylor Wessing in the Shanghai office. As of 2007, he has been appointed as a partner of Taylor Wessing.

View speaker details

Gavin has over 17 years of experience in China healthcare industry. He leads Business Development and E-commerce for the Established Pharmaceuticals business of Abbott in China. Before joining Abbott, he took various Licensing & Acquisition and strategy roles in MSD China and L.E.K. Consulting. Gavin holds B. Econ from University of International Business and Economics and Msc. from London School of Economics, he also studied Pharmaceutical part-time in SJTU with Bachelor of Science.

View speaker details

Kevin is leading Halma’s corporate strategic initiatives and its M&A efforts in Asia Pacific. In this role, he dedicates to amplifying Halma’s sustainability impacts by acquiring good businesses in markets with long term growth drivers and aligned to Halma’s Purpose. Working with the Group senior leadership, he helps formulate in-country strategies that align with the policies and development needs of China. He also partners with various Operating Companies across the portfolio on market development opportunities, with a focus on technology bolt-on and geographic expansion. Prior to joining Halma, Kevin worked in the Chinese private equity industry focusing on outbound M&A buyout in smart sensing, advanced manufacturing and semiconductors. His international career includes over a decade of commercial and technical roles serving a diverse range of industries. During his time at ExxonMobil Houston, Kevin invented and holds 3 worldwide patents. Kevin graduated summa cum laude with a B.S. chemical engineering from UC Berkeley. He holds an M.S. from MIT, M.Sc from the National University of Singapore and MBA from Tsinghua University.

View speaker details

With over 19-years experiences in multinational corporation’s legal affairs management and compliance, Victor used to work in a Hong Kong red-chip mobile communication company, a multi-national cosmetics company, and a world-class retail conglomerate. His extensive experience has equipped him with rich business knowledge of various industries, a sharp sense of different industry sectors and legal practice experiences. Victor has worked at Henkel for over 13 years, during which he has led his team handled numerous and complicated legal affairs and projects in the areas of international & domestic restructuring, divesture, mergers & acquisitions, labor, anti-trust, tax, customs, dispute resolution, government affairs, compliance and corporate governance. Victor’s performances has won him a high recognition from the Headquarters’ management, and he was elected as one of the Top General Counsel in 2015 by Asia Legal Business of Thomson Reuters and ranked one of GC Influencer of Greater China by Chambers in 2018 and 2019 consecutively as well as GC Power-list by Legal500 for consecutive years. Victor’s current practices and study interests concentrate on the legal systems of foreign direct investment, anti-trust, mergers & acquisitions, tax law, compliance and corporate law. Victor is also an active columnist at LexisNexis China and is invited from time to time by professional forums as the guest speaker on the above-mentioned areas.

View speaker details

Dr. Richard Zhang has been working in China since 1995 in senior executive level positions at several German chemical companies, among others Merck (Germany), Sued Chemie and Heraeus. Currently Dr. Zhang is serving as the Managing Director of Pulcra Chemicals, Greater China.

Born in Shanghai, Dr. Zhang was one of the 1st dispatched oversea students by Chinese government in 1980. He had spent almost eleven years in Germany, where he completed his entire Chemistry study with a Ph.D. (Dr.-Ing.) degree at the Technical University Darmstadt late 1990. Then he worked first in Singapore as a Research Fellow at the National University of Singapore (NUS), and later in Melbourne at Merck Australia as Product Manager for a few years.

Returning to Shanghai in 1995, Dr. Zhang was “No.1” staff who built up Merck China business and organization from start-up. He had spent altogether eighteen years at Merck, of which fifteen years in China. Apart being the Managing Director (Geschaeftsfuehrer) for Greater China, he was then also a member of the Global Senior Leadership Team at Merck.

During his time ((2011-2012) at Sued Chemie, Dr. Zhang led the integration of the entire Sued Chemie business and organization in Greater China into the Clariant Group. During his tenure at Heraeus Dr. Zhang set up the Regional HQ for Greater China. Furthermore, to the introduction of several new investment projects to China, he set up, expanded the scope and improved professionalism of the corporate functions at the Regional HQ. He was the only member of the Heraeus Group Executive Committee from Asia. Since he joined Pulcra in August 2018, he has persuaded the board of management speeded up the investment in China. The Delta project was launched in December 2019 which enlisted as 1 of 10 major foreign investment projects in municipal level.

Dr. Zhang also participates in various industry associations in China. Over the years he has served in numerous association's board and advisory board such as AnalyticaChina, Association of the International Chemical Manufacturers and the European Chamber of Commerce in China etc.

Dr. Zhang is the author and co-editor to two recent books on the topics of Governance, Risk and Compliance Management in China, published in Germany.

In 2016 Dr. Zhang received "Magnolia Award" from the Shanghai Municipal Government. He is a long-time member of the Rotary Club International.